Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Living Cancer CALM: A Pilot Hybrid Culinary And Lifestyle Medicine (CALM) Education Program for Cancer Risk Reduction Among Survivors of Breast Cancer

NCT07906990 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07906990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Living Cancer CALM: A Pilot Hybrid Culinary And Lifestyle Medicine (CALM) Education Program for Cancer Risk Reduction Among Survivors of Breast Cancer
Lead sponsor
Case Comprehensive Cancer Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 16, 2026
Completion date
June 3, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer

Arms

As registered; 1 arm.

  • Breast Cancer Survivors ExperimentalLiving Cancer CALM education intervention

    Eight 90 minute lessons delivered bi-weekly in the evenings in a hybrid format with alternating virtual and in-person lessons.

Primary endpoints

Registered primary outcome measures; 4 primary.

  • Rates of recruitment up to 18 weeks

    Feasibility and acceptability will be evaluated using rates of recruitment

  • Rates of retention up to 18 weeks

    Feasibility and acceptability will be evaluated using rates of retention

  • Rates of attendance up to 18 weeks

    Feasibility and acceptability will be evaluated using rates of attendance

  • Acceptability scores up to 18 weeks

    Feasibility and acceptability will be evaluated using acceptability scores

Lead sponsor's other trials

Case Comprehensive Cancer Center, most recent start first.

Similar trials

Same condition (Breast Neoplasms) and phase, most recent start first.